SCHEMBL6287870

SCHEMBL6287870

Cc1[nH]c2ccccc2c1CC(=O)[C@](N)(CCCNC(N)=O)C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@@](N)(CCCNC(N)=O)C(=O)Cc3c(C)[nH]c4ccccc34)cc2)c2ccc(NC(=O)[C@@](N)(CCCNC(N)=O)C(=O)Cc3c(C)[nH]c4ccccc34)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 2/20 0.40
GAA P10253 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
KLK6 Q92876 2/20 0.38
PABPC1 P11940 1/20 0.38
ALOX15 P16050 1/20 0.38
HDAC1 Q13547 3/20 0.36
HDAC3 O15379 2/20 0.36
HDAC4 P56524 2/20 0.36
HDAC2 Q92769 2/20 0.36
HDAC8 Q9BY41 2/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
TDP1 Q9NUW8 2/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6286857 0.93 MAPT (0.39) MAPTKDM4EALDH1A1GAACASP1
SCHEMBL7030590 0.91 MTNR1A (0.41) MAPTKDM4EALDH1A1GAACASP1
SCHEMBL6287910 0.89 KDM4E (0.42) MAPTKDM4EALDH1A1GAACASP1
Hydrochloric Acid SCHEMBL6287751 0.88 KDM4E (0.42) MAPTKDM4EALDH1A1GAACASP1
SCHEMBL6287338 0.88 MAPT (0.43) MAPTKDM4EALDH1A1GAACASP1
SCHEMBL6291008 0.87 CAMK2D (0.42) MAPTKDM4EALDH1A1GAACASP1
SCHEMBL6290892 0.87 AKR1C2 (0.46) MAPTALDH1A1GAAHDAC1TDP1
SCHEMBL6290659 0.86 MAPT (0.45) MAPTKDM4EALDH1A1GAACASP1
SCHEMBL6286770 0.82 GOT1 (0.41) MAPTALDH1A1TDP1KMT2AMEN1
SCHEMBL6290352 0.80 MAPT (0.41) MAPTKDM4EALDH1A1GAACASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK MAPT 4866/4885KDM4E 2972/4885ALDH1A1 2042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.